DCT

3:18-cv-14305

Valeant Pharma North America LLC v. Mylan Pharma Inc

General
Filed
09/26/18
Cause of ActionInfringement
SectorBiotech
Status
Closed (09/10/19)
Patent Owner
NPE (L)
Appeals19-2402
Judge
Period
PO Win Rate
--
71%